• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对未接受过抗逆转录病毒治疗的慢性 HIV-1 CRF07_BC 感染的静脉吸毒者中的中和抗体反应进行分析。

Profiling the neutralizing antibody response in chronically HIV-1 CRF07_BC-infected intravenous drug users naïve to antiretroviral therapy.

机构信息

State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing 102206, PR China.

Departments of Experimental Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.

出版信息

Sci Rep. 2017 Apr 7;7:46308. doi: 10.1038/srep46308.

DOI:10.1038/srep46308
PMID:28387330
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5384219/
Abstract

Characterizing neutralizing antibody (NAb) responses in individuals infected with diverse HIV-1 strains is necessary to reveal the novel targets for regional preventive and therapeutic strategies development. We evaluated the prevalence, breadth, and potency of NAb responses in 98 CRF07_BC-infected individuals using a large, multi-subtype panel of 30 tier 2-3 Env-pseudotyped viruses. Furthermore, we compared the neutralization pattern of CRF07_BC-infected people with that of subtype B'-infected individuals in China. Of the 98 plasma samples tested, 18% neutralized more than 80% of viruses in the panel, and 53% neutralized more than 50%, suggesting the presence of broadly NAbs in these individuals. A preferential intra-subtype neutralization of CRF07_BC was found. Notably, CRF07_BC-infected individuals generated higher neutralization titers against intra-subtype viruses than subtype B'-infected individuals with longer infection length. However, subtype B'-infected individuals mounted broader neutralization responses against inter-subtype viruses than CRF07_BC infection with shorter infection time, indicating the transition from narrow autologous to broad heterologous neutralization over time. Neutralization activity of the top six plasmas from each cohort was attributable to IgG fraction, and half of them developed CD4 binding site antibody reactivity. Heatmap analysis identified three statistically robust clusters of plasmas that offer valuable resources for further in-depth virological and immunological study.

摘要

对感染不同 HIV-1 毒株的个体中的中和抗体 (NAb) 反应进行特征分析,对于揭示新的区域性预防和治疗策略开发目标非常必要。我们使用一个包含 30 种 2-3 级包膜假型病毒的大型多亚型面板,评估了 98 名 CRF07_BC 感染者中 NAb 反应的流行率、广度和效力。此外,我们比较了中国 CRF07_BC 感染者与 B'亚型感染者的中和模式。在 98 个测试的血浆样本中,有 18%的样本能中和该面板中超过 80%的病毒,53%的样本能中和超过 50%的病毒,这表明这些个体中存在广泛的 NAb。发现 CRF07_BC 存在偏向于同亚型的中和。值得注意的是,与感染时间较长的 B'亚型感染者相比,CRF07_BC 感染者针对同亚型病毒产生了更高的中和滴度。然而,与 CRF07_BC 感染相比,感染时间较短的 B'亚型感染者对跨亚型病毒产生了更广泛的中和反应,表明随着时间的推移,从狭窄的自体中和向广泛的异体中和转变。来自每个队列的前六份血浆的中和活性归因于 IgG 部分,其中一半产生了 CD4 结合位点抗体反应性。热图分析确定了三个具有统计学意义的稳定血浆簇,为进一步深入的病毒学和免疫学研究提供了有价值的资源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8f/5384219/67b45d9ceb06/srep46308-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8f/5384219/d6bdc6f5b3a9/srep46308-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8f/5384219/c57f62febd21/srep46308-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8f/5384219/c67021dd3466/srep46308-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8f/5384219/f8a9d164ef24/srep46308-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8f/5384219/67b45d9ceb06/srep46308-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8f/5384219/d6bdc6f5b3a9/srep46308-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8f/5384219/c57f62febd21/srep46308-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8f/5384219/c67021dd3466/srep46308-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8f/5384219/f8a9d164ef24/srep46308-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8f/5384219/67b45d9ceb06/srep46308-f5.jpg

相似文献

1
Profiling the neutralizing antibody response in chronically HIV-1 CRF07_BC-infected intravenous drug users naïve to antiretroviral therapy.对未接受过抗逆转录病毒治疗的慢性 HIV-1 CRF07_BC 感染的静脉吸毒者中的中和抗体反应进行分析。
Sci Rep. 2017 Apr 7;7:46308. doi: 10.1038/srep46308.
2
Profiles of neutralizing antibody response in chronically human immunodeficiency virus type 1 clade B'-infected former plasma donors from China naive to antiretroviral therapy.中国慢性 HIV-1 型 B′组感染且未接受过抗病毒治疗的前血浆供者的中和抗体反应特征。
J Gen Virol. 2012 Oct;93(Pt 10):2267-2278. doi: 10.1099/vir.0.043802-0. Epub 2012 Jul 12.
3
Neutralization sensitivity of HIV-1 subtype B' clinical isolates from former plasma donors in China.中国既往血浆供者中 HIV-1 亚型 B'临床分离株的中和敏感性。
Virol J. 2013 Jan 5;10:10. doi: 10.1186/1743-422X-10-10.
4
Comparisons of the genetic and neutralization properties of HIV-1 subtype C and CRF07/08_BC env molecular clones isolated from infections in China.比较中国分离的 HIV-1 亚型 C 和 CRF07/08_BC 包膜分子克隆的遗传和中和特性。
Virus Res. 2011 Jan;155(1):137-46. doi: 10.1016/j.virusres.2010.09.012. Epub 2010 Sep 25.
5
Identification and characterization of broadly cross-reactive neutralizing antibodies in patients infected with HIV-1 B'/C recombinant (CRF07_BC).鉴定和分析感染 HIV-1 B'/C 重组型(CRF07_BC)病毒的患者体内广谱交叉中和抗体。
Mol Med Rep. 2012 May;5(5):1311-7. doi: 10.3892/mmr.2012.790. Epub 2012 Feb 14.
6
Broadly Neutralizing Antibody Responses in a Subset of HIV-1-Infected Individuals in Chennai, India.印度钦奈部分HIV-1感染个体中的广泛中和抗体反应
J Int Assoc Provid AIDS Care. 2017 Mar/Apr;16(2):201-208. doi: 10.1177/1545109712467695. Epub 2016 Jul 7.
7
Phenotypic and genotypic characterization of human immunodeficiency virus type 1 CRF07_BC strains circulating in the Xinjiang Province of China.中国新疆地区流行的1型人类免疫缺陷病毒CRF07_BC毒株的表型和基因型特征
Retrovirology. 2009 May 14;6:45. doi: 10.1186/1742-4690-6-45.
8
Comparison of the genotypic and phenotypic properties of HIV-1 standard subtype B and subtype B/B' env molecular clones derived from infections in China.比较源自中国感染的 HIV-1 标准亚型 B 和亚型 B/B' 包膜(env)基因克隆的基因型和表型特征。
Emerg Microbes Infect. 2018 May 16;7(1):90. doi: 10.1038/s41426-018-0087-0.
9
Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency.抗V3/聚糖和抗膜近端外部区域(MPER)中和抗体,而非抗V2/聚糖位点抗体,与更强的抗HIV-1中和广度和效力密切相关。
J Virol. 2015 May;89(10):5264-75. doi: 10.1128/JVI.00129-15. Epub 2015 Feb 11.
10
Genetic and neutralization properties of HIV-1 env clones from subtype B/BC/AE infections in China.中国B/BC/AE亚型感染的HIV-1 env克隆的遗传与中和特性
J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):535-43. doi: 10.1097/QAI.0b013e3181663967.

引用本文的文献

1
An HIV-1/HIV-2 Chimeric Envelope Glycoprotein Generates Binding and Neutralising Antibodies against HIV-1 and HIV-2 Isolates.一种 HIV-1/HIV-2 嵌合包膜糖蛋白可产生针对 HIV-1 和 HIV-2 分离株的结合和中和抗体。
Int J Mol Sci. 2023 May 22;24(10):9077. doi: 10.3390/ijms24109077.
2
Identification of a novel broadly HIV-1-neutralizing antibody from a CRF01_AE-infected Chinese donor.从一名感染 CRF01_AE 型 HIV-1 的中国供体中鉴定出一种新型广谱中和抗体。
Emerg Microbes Infect. 2018 Nov 1;7(1):174. doi: 10.1038/s41426-018-0175-1.
3
Multi-Envelope HIV-1 Vaccine Development: Two Targeted Immune Pathways, One Desired Protective Outcome.

本文引用的文献

1
Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin Mice.序贯免疫在Ig基因敲入小鼠中引发广泛中和性抗HIV-1抗体。
Cell. 2016 Sep 8;166(6):1445-1458.e12. doi: 10.1016/j.cell.2016.07.030.
2
Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice.经过特定修饰的Env免疫原可激活转基因小鼠体内广泛中和HIV-1抗体的B细胞前体。
Nat Commun. 2016 Feb 24;7:10618. doi: 10.1038/ncomms10618.
3
HIV-1 Envelope Trimer Design and Immunization Strategies To Induce Broadly Neutralizing Antibodies.
多包膜HIV-1疫苗研发:两条靶向免疫途径,一个预期的保护结果。
Viral Immunol. 2018 Mar;31(2):124-132. doi: 10.1089/vim.2017.0144. Epub 2018 Jan 9.
4
Identification of a novel HIV-1-neutralizing antibody from a CRF07_BC-infected Chinese donor.从一名感染CRF07_BC的中国捐赠者中鉴定出一种新型HIV-1中和抗体。
Oncotarget. 2017 Jun 21;8(38):63047-63063. doi: 10.18632/oncotarget.18594. eCollection 2017 Sep 8.
诱导广泛中和抗体的HIV-1包膜三聚体设计与免疫策略
Trends Immunol. 2016 Mar;37(3):221-232. doi: 10.1016/j.it.2016.01.007. Epub 2016 Feb 9.
4
Geographic origin and evolutionary history of China's two predominant HIV-1 circulating recombinant forms, CRF07_BC and CRF08_BC.中国两种主要的HIV-1循环重组型CRF07_BC和CRF08_BC的地理起源及进化史。
Sci Rep. 2016 Jan 14;6:19279. doi: 10.1038/srep19279.
5
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection.广泛中和抗体 VRC01 在慢性 HIV-1 感染期间的病毒学效应。
Sci Transl Med. 2015 Dec 23;7(319):319ra206. doi: 10.1126/scitranslmed.aad5752.
6
Prime-boost vaccine strategy against viral infections: Mechanisms and benefits.针对病毒感染的初免-加强疫苗策略:作用机制与益处
Vaccine. 2016 Jan 20;34(4):413-423. doi: 10.1016/j.vaccine.2015.11.062. Epub 2015 Dec 13.
7
HIV-1 VACCINES. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen.HIV-1疫苗。使用靶向种系的免疫原引发对HIV-1的广泛中和抗体反应。
Science. 2015 Jul 10;349(6244):156-61. doi: 10.1126/science.aac5894. Epub 2015 Jun 18.
8
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.在HIV-1感染的人类中,广谱中和抗体3BNC117可抑制病毒血症。
Nature. 2015 Jun 25;522(7557):487-91. doi: 10.1038/nature14411. Epub 2015 Apr 8.
9
Reconstitution and characterization of antibody repertoires of HIV-1-infected "elite neutralizers".重建和鉴定 HIV-1 感染的“精英中和抗体”的抗体库。
Antiviral Res. 2015 Jun;118:1-9. doi: 10.1016/j.antiviral.2015.02.006. Epub 2015 Mar 12.
10
Virological features associated with the development of broadly neutralizing antibodies to HIV-1.与针对HIV-1的广泛中和抗体产生相关的病毒学特征。
Trends Microbiol. 2015 Apr;23(4):204-11. doi: 10.1016/j.tim.2014.12.007. Epub 2015 Jan 5.